Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

HB24 helps convert IBA to IAA, promoting root hair growth.

Targeting CXCL12 may help treat hair loss caused by androgens.

FLCN helps control iron levels in cells.

Overexpression of Hoxc13 in hair cells causes hair loss and skin issues.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Activating Notch signaling can kill basal cell carcinoma cells.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

ELF5 is essential for skin cell growth and maintenance.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Clascoterone is safe for the heart, even at high doses.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Astraglus polysaccharide may help hair growth by boosting follicle stem cell activity.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

BBS7 is crucial for maintaining healthy periodontal ligaments by supporting Shh signaling.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A specific RNA modification in cashmere goats helps activate hair growth-related stem cells.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.